Tadashi Shimada
St. Luke's International Hospital · 13 works · 694 citations · h-index 5
Top works
- CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study
- Three-Year Follow-Up of an Alectinib Phase I/II Study in ALK-Positive Non–Small-Cell Lung Cancer: AF-001JP
- A phase I/II study with a CNS-penetrant, selective ALK inhibitor alectinib in ALK-rearranged non-small cell lung cancer (ALK+ NSCLC) patients (pts): Updates on progression free survival (PFS) and safety results from AF-001JP.
- Pharmacologic study ( JP 28927) of alectinib in Japanese patients with ALK+ non‐small‐cell lung cancer with or without prior crizotinib therapy
- A phase I/II study with a highly selective ALK inhibitor CH5424802 in ALK-positive non-small cell lung cancer (NSCLC) patients: Updated safety and efficacy results from AF-001JP.
- Vemurafenib (ZELBORAF® tablet 240 mg): pharmacological properties and clinical development overview
- GABAergic mechanisms in the rat motor cortex during neuroleptanalgesia with diazepam and pentazocine
- Desensitization of Ca2+-dependent intracellular alkalization by muscarinic stimulation with carbachol in smooth muscle.
- Effects of atropine on the long-term potentiation of intracortical direct responses in rat motor cortex
- Blocking effects of brainstem stimulation on urethane-induced electro-cortical slow waves in the rat.
- Electrocortical and neuronal activities of rat motor cortex in anesthesia by diazepam with analgesics.
- Synaptic mechanisms of urethane-induced electrocortical slow waves in the rat
- Electrocortical and neuronal activities of rat motor cortex in neuroleptanalgesia with droperidol and pentazocine